Drugs Made In America Acquisition II Corp
DMII
69 hedge funds and large institutions have $457M invested in Drugs Made In America Acquisition II Corp in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
2.41% more ownership
Funds ownership: 68.96% → 71.37% (+2.4%)
1% more funds holding
Funds holding: 68 → 69 (+1)
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
4% more capital invested
Capital invested by funds: $438M → $457M (+$19.3M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
+$20.2M |
| 2 |
CA
Crossingbridge Advisors
Pleasantville,
New York
|
+$7.53M |
| 3 |
TAL
TIG Advisors LLC
New York
|
+$5.02M |
| 4 |
JP Morgan Chase
New York
|
+$4.28M |
| 5 |
LSC
Logan Stone Capital
Chicago,
Illinois
|
+$3.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$20M |
| 2 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$10.8M |
| 3 |
SC
Sculptor Capital
New York
|
-$4.99M |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$2.45M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$1.49M |
DMII Hedge Fund Activity: Q2 2026 in Review
69 of the 8,334 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp (DMII) for Q2 2026, worth a combined $457M — up 4.4% from $438M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new DMII positions and 5 closed out — a net gain of 1 holder — while 15 added to existing stakes and 14 trimmed.
The largest buyer was Highbridge Capital Management, adding an estimated $20.2M. The largest seller was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, exiting entirely with an estimated $20M sold.
- 69 institutional investors held Drugs Made In America Acquisition II Corp (DMII) as of Q2 2026, up from 68 in Q1 2026.
- Funds reported $457M of Drugs Made In America Acquisition II Corp stock for Q2 2026, up 4.4% quarter-over-quarter.
- 6 funds opened new Drugs Made In America Acquisition II Corp positions in Q2 2026 and 5 closed out, a net change of +1 holder.
- The largest Drugs Made In America Acquisition II Corp buyer in Q2 2026 was Highbridge Capital Management, an estimated $20.2M added.
- The largest Drugs Made In America Acquisition II Corp seller in Q2 2026 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $20M sold.
Based on aggregated 13F filings for Q2 2026.